Literature DB >> 19324119

Surgeon specialty and long-term survival after pulmonary resection for lung cancer.

Farhood Farjah1, David R Flum, Thomas K Varghese, Rebecca Gaston Symons, Douglas E Wood.   

Abstract

BACKGROUND: Long-term outcomes and processes of care in patients undergoing pulmonary resection for lung cancer may vary by surgeon type. Associations between surgeon specialty and processes of care and long-term survival have not been described.
METHODS: A cohort study (1992 through 2002, follow-up through 2005) was conducted using Surveillance, Epidemiology, and End-Results-Medicare data. The American Board of Thoracic Surgery Diplomates list was used to differentiate board-certified thoracic surgeons from general surgeons (GS). Board-certified thoracic surgeons were designated as cardiothoracic surgeons (CTS) if they performed cardiac procedures and as general thoracic surgeons (GTS) if they did not.
RESULTS: Among 19,745 patients, 32% were cared for by GTS, 45% by CTS, and 24% by GS. Patient age, comorbidity index, and resection type did not vary by surgeon specialty (all p > 0.10). Compared with GS and CTS, GTS more frequently used positron emission tomography (36% versus 26% versus 26%, respectively; p = 0.005) and lymphadenectomy (33% versus 22% versus 11%, respectively; p < 0.001). After adjustment for patient, disease, and management characteristics, hospital teaching status, and surgeon and hospital volume, patients treated by GTS had an 11% lower hazard of death compared with those who underwent resection by GS (hazard ratio, 0.89; 99% confidence interval, 0.82 to 0.97). The risks of death did not vary significantly between CTS and GS (hazard ratio, 0.94; 99% confidence interval, 0.88 to 1.01) or GTS and CTS (hazard ratio, 0.94; 99% confidence interval, 0.87 to 1.03).
CONCLUSIONS: Lung cancer patients treated by GTS had higher long-term survival rates than those treated by GS. General thoracic surgeons performed preoperative and intraoperative staging more often than GS or CTS.

Entities:  

Mesh:

Year:  2009        PMID: 19324119     DOI: 10.1016/j.athoracsur.2008.12.030

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  36 in total

1.  Improving lung cancer outcomes by improving the quality of surgical care.

Authors:  Raymond U Osarogiagbon; Thomas A D'Amico
Journal:  Transl Lung Cancer Res       Date:  2015-08

Review 2.  What is quality, and can we define it in lung cancer?-the case for quality improvement.

Authors:  Farhood Farjah; Frank C Detterbeck
Journal:  Transl Lung Cancer Res       Date:  2015-08

3.  VATS lobectomy lymph node management.

Authors:  Gavin M Wright
Journal:  Ann Cardiothorac Surg       Date:  2012-05

4.  Trends in the utilization and impact of radiofrequency ablation for hepatocellular carcinoma.

Authors:  Nader N Massarweh; James O Park; Farhood Farjah; Raymond S W Yeung; Rebecca Gaston Symons; Thomas L Vaughan; Laura-Mae Baldwin; David R Flum
Journal:  J Am Coll Surg       Date:  2010-04       Impact factor: 6.113

Review 5.  Preoperative evaluation for lung cancer resection.

Authors:  Dionysios Spyratos; Paul Zarogoulidis; Konstantinos Porpodis; Nikolaos Angelis; Antonios Papaiwannou; Ioannis Kioumis; Georgia Pitsiou; Athanasia Pataka; Kosmas Tsakiridis; Andreas Mpakas; Stamatis Arikas; Nikolaos Katsikogiannis; Ioanna Kougioumtzi; Theodora Tsiouda; Nikolaos Machairiotis; Stavros Siminelakis; Michael Argyriou; Maria Kotsakou; George Kessis; Alexander Kolettas; Thomas Beleveslis; Konstantinos Zarogoulidis
Journal:  J Thorac Dis       Date:  2014-03       Impact factor: 2.895

6.  The Victorian Lung Cancer Registry pilot: improving the quality of lung cancer care through the use of a disease quality registry.

Authors:  Rob G Stirling; S M Evans; P McLaughlin; M Senthuren; J Millar; J Gooi; L Irving; P Mitchell; A Haydon; J Ruben; M Conron; T Leong; N Watkins; J J McNeil
Journal:  Lung       Date:  2014-06-08       Impact factor: 2.584

7.  Disclosure of surgeon experience.

Authors:  Sabha Ganai
Journal:  World J Surg       Date:  2014-07       Impact factor: 3.352

8.  Outcomes after Video-assisted Thoracoscopic Lobectomy versus Open Lobectomy for Early-Stage Lung Cancer in Older Adults.

Authors:  Nicole Ezer; Minal Kale; Keith Sigel; Sameer Lakha; Grace Mhango; Emily Goodman; Daniel Nicastri; Scott Swanson; Alfred Neugut; Juan P Wisnivesky
Journal:  Ann Am Thorac Soc       Date:  2018-01

9.  Socioeconomic risk factors for long-term mortality after pulmonary resection for lung cancer: an analysis of more than 90,000 patients from the National Cancer Data Base.

Authors:  Onkar V Khullar; Theresa Gillespie; Dana C Nickleach; Yuan Liu; Kristin Higgins; Suresh Ramalingam; Joseph Lipscomb; Felix G Fernandez
Journal:  J Am Coll Surg       Date:  2014-10-27       Impact factor: 6.113

10.  High expression of Toll-like receptor 5 correlates with better prognosis in non-small-cell lung cancer: an anti-tumor effect of TLR5 signaling in non-small cell lung cancer.

Authors:  Hui Zhou; Jian-hua Chen; Jun Hu; Yong-zhong Luo; Fang Li; Ling Xiao; Mei-zuo Zhong
Journal:  J Cancer Res Clin Oncol       Date:  2014-02-19       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.